Q1 2022 13F Holders as of 3/31/2022
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
392M
-
Number of holders
-
838
-
Total 13F shares, excl. options
-
94.5M
-
Shares change
-
+2.3M
-
Total reported value, excl. options
-
$48.2B
-
Value change
-
+$1.14B
-
Put/Call ratio
-
1.17
-
Number of buys
-
399
-
Number of sells
-
-429
-
Price
-
$511.60
Significant Holders of DEXCOM INC - Common Stock (DXCM) as of Q1 2022
1,035 filings reported holding DXCM - DEXCOM INC - Common Stock as of Q1 2022.
DEXCOM INC - Common Stock (DXCM) has 838 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 94.5M shares
of 392M outstanding shares and own 24.1% of the company stock.
Largest 10 shareholders include VANGUARD GROUP INC (10.6M shares), BlackRock Inc. (8.44M shares), BAILLIE GIFFORD & CO (4.55M shares), SANDS CAPITAL MANAGEMENT, LLC (4.19M shares), STATE STREET CORP (4.02M shares), FMR LLC (3.79M shares), JPMORGAN CHASE & CO (2.84M shares), Capital Research Global Investors (2.64M shares), JENNISON ASSOCIATES LLC (2.6M shares), and Nuveen Asset Management, LLC (2.2M shares).
This table shows the top 838 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.